| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.0M | +4.1% |
| Cost of Revenue | $4.3M | -24.7% |
| Gross Profit | $3.7M | +87.2% |
| R&D Expense | $5.1M | -18.3% |
| SG&A Expense | $16.4M | -19.2% |
| Operating Income | -$17.7M | +27.6% |
| Income Tax | $0 | — |
| Net Income | -$17.6M | +27.9% |
| EPS (Basic) | -$0.43 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $5.3M | +8.0% |
| Short-term Investments | $13.9M | -53.5% |
| Accounts Receivable | $2.8M | -26.7% |
| Inventory | $4.0M | +153.8% |
| Current Assets | $26.9M | -34.8% |
| Total Assets | $30.6M | -30.9% |
| Current Liabilities | $3.2M | +10.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$14.6M | +19.9% |
| Capital Expenditures | $256K | -74.3% |
| Investing Cash Flow | $14.9M | +315.0% |
| Financing Cash Flow | $83K | -99.4% |
| Free Cash Flow | -$14.9M | +22.7% |
| +30.6% |
| Total Liabilities |
| $3.5M |
| +18.5% |
| Stockholders' Equity | $27.1M | -34.4% |